COMPASS Pathways plc (CMPS)
USD 4.19
(2.2%)
USD 4.19
(2.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -242.93 Thousand USD | 26.34% |
| 2022 | -329.79 Thousand USD | -88.48% |
| 2021 | -174.97 Thousand USD | -56.23% |
| 2020 | -112 Thousand USD | -77.78% |
| 2019 | -63 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | - USD | 100.0% |
| 2024 Q2 | -63.07 Thousand USD | -3.45% |
| 2024 Q1 | -60.96 Thousand USD | -103.31% |
| 2023 Q1 | -592.32 Thousand USD | -512.42% |
| 2023 FY | -242.93 Thousand USD | 26.34% |
| 2023 Q4 | 1.84 Million USD | 379.78% |
| 2023 Q3 | -658.15 Thousand USD | -11.38% |
| 2023 Q2 | -590.89 Thousand USD | 0.24% |
| 2022 Q2 | -99.12 Thousand USD | -84.63% |
| 2022 Q1 | -53.69 Thousand USD | -3.13% |
| 2022 FY | -329.79 Thousand USD | -88.48% |
| 2022 Q4 | -96.71 Thousand USD | 2.45% |
| 2022 Q3 | -99.14 Thousand USD | -0.02% |
| 2021 FY | -174.97 Thousand USD | -56.23% |
| 2021 Q4 | -52.06 Thousand USD | 47.7% |
| 2021 Q3 | -99.55 Thousand USD | 0.25% |
| 2021 Q2 | -99.8 Thousand USD | -184.17% |
| 2021 Q1 | -35.12 Thousand USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 FY | -112 Thousand USD | -77.78% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | -63 Thousand USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 682.6 Million USD | 100.036% |
| Addus HomeCare Corporation | 339.87 Million USD | 100.071% |
| AirSculpt Technologies, Inc. | 121.9 Million USD | 100.199% |
| Amedisys, Inc. | 457.07 Million USD | 100.053% |
| Astrana Health, Inc. | 214.95 Million USD | 100.113% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 100.041% |
| IMAC Holdings, Inc. | 3.84 Million USD | 106.312% |
| biote Corp. | 127.48 Million USD | 100.191% |
| Cryo-Cell International, Inc. | 22.9 Million USD | 101.061% |
| Cross Country Healthcare, Inc. | 432.06 Million USD | 100.056% |
| DocGo Inc. | 178.95 Million USD | 100.136% |
| The Ensign Group, Inc. | 590.75 Million USD | 100.041% |
| Healthcare Services Group, Inc. | 251.45 Million USD | 100.097% |
| InnovAge Holding Corp. | 132.06 Million USD | 100.184% |
| The Joint Corp. | 107.14 Million USD | 100.227% |
| LifeStance Health Group, Inc. | 302.09 Million USD | 100.08% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 77.33% |
| ModivCare Inc. | 446.95 Million USD | 100.054% |
| NewGenIvf Group Limited | 1.68 Million USD | 114.445% |
| Option Care Health, Inc. | 981.22 Million USD | 100.025% |
| P3 Health Partners Inc. | 31.63 Million USD | 100.768% |
| P3 Health Partners Inc. | 31.63 Million USD | 100.768% |
| The Pennant Group, Inc. | 61.9 Million USD | 100.392% |
| Surgery Partners, Inc. | 529.4 Million USD | 100.046% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | 117.206% |
| Talkspace, Inc. | 74.38 Million USD | 100.327% |
| Talkspace, Inc. | 74.38 Million USD | 100.327% |
| The Oncology Institute, Inc. | 59.57 Million USD | 100.408% |
| The Oncology Institute, Inc. | 59.57 Million USD | 100.408% |